Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in Lupus Nephritis (ACCESS)
NCT00774852Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2008
- Primary completion
- Dec 2012
- Countries
- 2
01
Overview
A Phase 2 trial of abatacept in lupus nephritis (LN), sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2008; status: completed.
02
Drugs
abatacept
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT00774852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00774852.